Gov. Mike DeWine (R) will not support a bill that would essentially ban vaccine passports from the state of Ohio.
H.R. 248, called the “Vaccine Choice and Anti-discrimination Act,” would allow Ohioans to choose not to take the COVID-19 vaccine, and would allow parents to decide whether their children should take it. It would prevent the state or businesses from discriminating against those who have not taken the vaccine.
For the first time since churches were shut down during the COVID-19 pandemic, Catholics in Ohio were welcomed back to Mass on Sunday.
“As we move beyond the worst of the coronavirus pandemic and access to the COVID-19 vaccine has become more widespread, the time has arrived for the good of all the faithful when the general dispensation from the obligation to attend Mass on Sundays and Holy Days of Obligation is no longer necessary,” a mid-May statement from the Catholic Conference of Ohio said.
The first winners in Ohio’s vaccine lottery were chosen Wednesday night.
“Abbigail Bugenske of southwestern Ohio took home $1 million after she entered the drawing along with more than 2.7 million other vaccinated Ohioans,” Fox News reported.
As Ohio readies itself to choose the first winners in its “Vax-a-Million” lottery Monday, one Republican state lawmaker is drafting a bill in opposition to Republican Gov. Mike DeWine’s plan.
State Rep. Jena Powell (R-Arcanum) is writing legislation that would ban the vaccination lottery, according to multiple reports. She does not think Ohioans should be bribed with taxpayer money.
A majority of Americans said for the first time in over a year that returning to their “normal” pre-pandemic lives did not pose a moderate or large health risk, an Axios/Ipsos survey shows.
The survey, released Tuesday, showed just 43% of Americans saying that returning to “normal” posed either a large or moderate risk to their health. It also shows that majorities of Americans have begun to enjoy several aspects of pre-pandemic life: 54% of Americans have eaten at a restaurant, 59% have visited family or friends and 31% have made summer plans – all in the past week alone.
The return to normalcy and the mental health benefits associated with it directly corresponds with the amount of Americans who say they have been vaccinated. Almost two-thirds of respondents say that they have received at least one shot, and 18% say that their emotional well-being has improved in the past week, which the survey notes is an all-time high during the pandemic.
Wyoming Gov. Mark Gordon on Friday issued a directive blocking state agencies from using vaccine passports.
The directive requires state agencies, boards and commissions to “provide full access to state spaces and state services, regardless of a constituent’s COVID-19 vaccination status.”
The directive also urges local governments and private businesses to align their policies and practices with the state.
“Vaccine passport programs have the potential to politicize a decision that should not be politicized,” Gordon, a Republican, said in a statement. “They would divide our citizens at a time when unity in fighting the virus is essential, and harm those who are medically unable to receive the vaccine. While I strongly encourage Wyomingites over the age of 16 to get vaccinated against COVID-19, it is a personal choice based upon personal circumstances.”
The Pfizer and Moderna coronavirus vaccines are highly effective against and prevent illness from common variants of the virus, according to recently released studies.
The vaccine made by Pfizer is effective against the coronavirus variants that originated from the U.K. and South Africa, according to multiple studies released Wednesday that examined real-world vaccinations, The New York Times reported. Moderna reported that an early-stage trial suggested its vaccine is effective against the South African variant and a third variant originating from Brazil when given as a single-dose booster shot.
“At this point in time, we can confidently say that we can use this vaccine, even in the presence of circulating variants of concern,” London School of Hygiene and Tropical Medicine infectious disease researcher Annelies Wilder-Smith told the NYT.
Workers at a Baltimore plant responsible for producing two separate coronavirus vaccines mistakenly mixed up their respective ingredients, ruining approximately 15 million doses of Johnson & Johnson’s vaccine and pausing all production at the plant, the company confirmed Wednesday.
The facility, run by Emergent BioSolutions, had partnered with both Johnson & Johnson and AstraZeneca to produce vaccines. Federal officials said that the mistake was a result of human error, according to The New York Times, which first reported the mix up that reportedly occurred several weeks ago.
A quality control review “identified one batch of drug substance that did not meet quality standards at Emergent BioSolutions, a site not yet authorized to manufacture drug substance for our COVID-19 vaccine,” Johnson & Johnson said in a statement. “This batch was never advanced to the filling and finishing stages of our manufacturing process.”
Maryland’s vile handling of the COVID-19 vaccine affords searing lessons in the failure of bureaucratic government or the administrative state. More specifically Montgomery County (MoCo), Maryland’s bedroom community for the federal bureaucracy, exemplifies how America will suffer under one-party Democratic rule.
In a 67-0 vote Monday, the Minnesota Senate passed legislation that will allow dentists to administer the COVID-19 vaccine.
SF 475 is a bill “amending Minnesota Statutes 2020, section 150A.055,” which gives dentists the ability to distribute influenza vaccines. The amendment broadens the original bill, extending to cover COVID-19 vaccinations, too.
Biotech company Moderna announced Monday that its new COVID-19 vaccine has proven to be 94.5 % effective.
The company said it intends to submit for an Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration in the coming weeks and expects the EUA to be based on the final analysis of 151 cases and a median follow-up of more than two months.
The Trump administration is expected to announce that the eventual coronavirus vaccine will be covered by Medicare and Medicaid, Politico reported late Monday.
The administration is expected to change a rule that previously prevented Medicare and Medicaid from covering vaccines that received emergency use authorization from the FDA. The official announcement is expected from the Center for Medicare and Medicaid Services (CMS) Tuesday or Wednesday, according to Politico.
Two drugmakers announced Friday the resumption of U.S. testing of their COVID-19 vaccine candidates.
Testing of AstraZeneca’s vaccine candidate had been halted since early September, while Johnson & Johnson’s vaccine study was paused at the beginning of last week. Each company had a study volunteer develop a serious health issue, requiring a review of safety data.
CVS Health announced that it would bring on approximately 15,000 additional workers in preparation for the upcoming flu season and an expected rise in coronavirus cases before the distribution of an eventual vaccine.
The hirings will take place before the year’s end, the company said Monday in a statement. Though most of the positions are temporary, many could transition into full-time positions, CVS said.
The suspension of a huge COVID-19 vaccine study over an illness in a single participant shows there will be “no compromises” on safety in the race to develop the shot, the chief of the National Institutes of Health told Congress on Wednesday.
AstraZeneca has put on hold studies of its vaccine candidate in the U.S. and other countries while it investigates whether a British volunteer’s illness is a side effect or a coincidence.